Interesting findings in NYC reported @NatureMedicine : immune checkpoint inhibitors not chemo or surgery was associated with higher risk of severe #COVID19 illness. https://t.co/z1DSRxuZM9
@GeneCollector @MiriamMerad A relevant study was also published in @NatureMedicine by @sloan_kettering https://t.co/c38DBmkbks
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @IdoAmitLab: Checkpoint inhibitors increase severity and steroids improve outcome. Data is starting to point to excessive immune- activa…
RT @IdoAmitLab: Checkpoint inhibitors increase severity and steroids improve outcome. Data is starting to point to excessive immune- activa…
RT @IdoAmitLab: Checkpoint inhibitors increase severity and steroids improve outcome. Data is starting to point to excessive immune- activa…
RT @IdoAmitLab: Checkpoint inhibitors increase severity and steroids improve outcome. Data is starting to point to excessive immune- activa…
RT @IdoAmitLab: Checkpoint inhibitors increase severity and steroids improve outcome. Data is starting to point to excessive immune- activa…
RT @Howard__Yim: #COVID19 patients with #Cancer who were at age >65 years & treated with immune checkpoint inhibitors had a higher risk of…
Determinants of COVID-19 disease severity in patients with cancer | Nature Medicine https://t.co/QW0kYednoG
RT @IdoAmitLab: Checkpoint inhibitors increase severity and steroids improve outcome. Data is starting to point to excessive immune- activa…
#COVID19 patients with #Cancer who were at age >65 years & treated with immune checkpoint inhibitors had a higher risk of getting severe COVID19 than those who received #chemotherapy & #surgery @NatureMedicine @MRC_microbiome @TCRNetwork @Cance
Checkpoint inhibitors increase severity and steroids improve outcome. Data is starting to point to excessive immune- activation as a significant pathological determinant || Determinants of COVID-19 disease severity in patients with cancer https://t.co/ERyc
Determinants of COVID-19 disease severity in patients with cancer. https://t.co/u0LIIP1mYD https://t.co/56gtpcZBbq
Interesting article from Memorial Sloan Kettering Cancer Center on impact of #checkpoint inhibitor use on #COVID19 outcomes in cancer pts --> more studies needed but some reason to be concerned and vigilant here #oncology #cancer… target="_blank" href="https://t.co/JReR6NY96">https://t.co/JReR6NY96
#NatureMedicine Determinants of COVID-19 disease severity in patients with cancer https://t.co/GZlyUk1RuQ
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
Poor outcomes for Covid-19 among patients who had been treated with drugs inhibiting PD-1 and CTLA-4. https://t.co/Q6Riqa9QO7
RT @LiorBraunstein: Among @sloan_kettering pts, age and immune checkpoint inhibitors (NOT chemotherapy OR surgery) associated w #COVID19 ho…
RT @LiorBraunstein: Among @sloan_kettering pts, age and immune checkpoint inhibitors (NOT chemotherapy OR surgery) associated w #COVID19 ho…
RT @LiorBraunstein: Among @sloan_kettering pts, age and immune checkpoint inhibitors (NOT chemotherapy OR surgery) associated w #COVID19 ho…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @LiorBraunstein: Among @sloan_kettering pts, age and immune checkpoint inhibitors (NOT chemotherapy OR surgery) associated w #COVID19 ho…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @LiorBraunstein: Among @sloan_kettering pts, age and immune checkpoint inhibitors (NOT chemotherapy OR surgery) associated w #COVID19 ho…
RT @DelthiaRicks: Researchers find that common #cancer treatments don't worsen #coronavirus infection. Study conducted at the height of the…
RT @LiorBraunstein: Among @sloan_kettering pts, age and immune checkpoint inhibitors (NOT chemotherapy OR surgery) associated w #COVID19 ho…
RT @NBSaphierMD: 💙
RT @DelthiaRicks: Researchers find that common #cancer treatments don't worsen #coronavirus infection. Study conducted at the height of the…
Among @sloan_kettering pts, age and immune checkpoint inhibitors (NOT chemotherapy OR surgery) associated w #COVID19 hosp & severe dz. Reassuring for those awaiting/receiving conventional rx. ?XRT @ErinGillespieMD @GeneCollector @imrtlee @seanmmcbride
RT @nresearchnews: A paper in @NatureMedicine suggests that advanced cancer, receipt of chemotherapy and recent cancer surgery might not ex…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
خبر جيد؟ 423مريض سرطان ب #كوفيد١٩ بمركزواحد بنيويورك وجد عدم إرتباط شدةالمرض بعلاج السرطان الكيماوي/الجراحي وإنما فيمن علىICIاوكورتيزون،سرطان دم،قلةخلايا اللمف،فوق65سنة،أو عرق غيرأبيض النتائج مختلفةعن إيطالياوالصين وتضيف الى دراستين أكبرCCC19وUKCCMP بانت
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @DelthiaRicks: Researchers find that common #cancer treatments don't worsen #coronavirus infection. Study conducted at the height of the…
Gilbert ! Gilbert ! Gilbert ! Ne fait pas le petit enfant et tend les fesses ! Elle a un un petit traitement spécialement pour toi ! A ton tour de faire le cobaye ! https://t.co/BzXoWy7TbD
RT @GilbertDeray: #Cancer et #Covid19 : les déterminants de la gravité Age >65 ans…
RT @GilbertDeray: #Cancer et #Covid19 : les déterminants de la gravité Age >65 ans…
#Cancer et #Covid19 : les déterminants de la gravité Age >65 ans Traitement par inhibiteur du « check point » (immunothérapie). https://t.co/NUmIZsn5Nh
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @DrMiguelPerales: #ASTCTChat @sloan_kettering paper just out today in @NatureMedicine Determinants of COVID-19 disease severity in patie…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @DelthiaRicks: Researchers find that common #cancer treatments don't worsen #coronavirus infection. Study conducted at the height of the…
Researchers find that common #cancer treatments don't worsen #coronavirus infection. Study conducted at the height of the pandemic in NYC by epidemiologists at Memorial Sloan Kettering Cancer Center. Image: Dividing cancer cell, Nat'l Cancer Institute http
RT @AMartinezRocaMD: Determinants of COVID-19 disease severity in patients with cancer. #COVID__19 #oncoalert https://t.co/eHWmGU0qEG
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @MuinJKhoury: What determines #COVID19 disease severity in patients with cancer? Via @NatureMedicine https://t.co/poBJ4w4ovF https://t.c…
Determinantes de la gravedad de la enfermedad #COVID-19 en pacientes con cáncer
RT @Transplant_Doc: Determinants of #COVID__19 disease severity in patients with #cancer https://t.co/I1O7NKjtsj @NatureMedicine #coronavi…
RT @DrMiguelPerales: #ASTCTChat @sloan_kettering paper just out today in @NatureMedicine Determinants of COVID-19 disease severity in patie…
Patients on active cancer treatment who develop COVID-19 infection don't fare worse than other hospitalized patients https://t.co/C7jnZk6aMy https://t.co/Uy3BCFMl8l
Interestingly, prior use of #immunecheckpoint inhibitors is a risk factor for severe disease, stressing the immune nature of some of the #COVID19 complications.
RT @Transplant_Doc: Determinants of #COVID__19 disease severity in patients with #cancer https://t.co/I1O7NKjtsj @NatureMedicine #coronavi…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @CDebyaniPhD: Intriguing research of our times: pts w/ cancer = 8.4% of ~9.3K deaths due to #COVID19 in #NewYork. @mini_kamboj @MichaelG…
RT @CDebyaniPhD: Intriguing research of our times: pts w/ cancer = 8.4% of ~9.3K deaths due to #COVID19 in #NewYork. @mini_kamboj @MichaelG…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @uranus_2: 65歳より高齢、免疫チェックポイント阻害薬での癌の治療が入院、重症を予測。一方、癌に対する化学療法や大手術は新型コロナでの入院や重症を予測するとはいえない。Determinants of COVID-19 disease severity in pa…
RT @uranus_2: 新型コロナウイルス感染症の症状がある癌患者において、新型コロナ関連で入院したのが40%。重症の呼吸器疾患になったのが20%で、その中には人工呼吸器が必要となった9%を含む。30日以内に死亡したのが12%。 https://t.co/ndR88k3nEj
Determinants of COVID-19 disease severity in patients with cancer | Nature Medicine https://t.co/WQce0owDev
65歳より高齢、免疫チェックポイント阻害薬での癌の治療が入院、重症を予測。一方、癌に対する化学療法や大手術は新型コロナでの入院や重症を予測するとはいえない。Determinants of COVID-19 disease severity in patients with cancer https://t.co/ndR88k3nEj
新型コロナウイルス感染症の症状がある癌患者において、新型コロナ関連で入院したのが40%。重症の呼吸器疾患になったのが20%で、その中には人工呼吸器が必要となった9%を含む。30日以内に死亡したのが12%。 https://t.co/ndR88k3nEj
RT @AMartinezRocaMD: Determinants of COVID-19 disease severity in patients with cancer. #COVID__19 #oncoalert https://t.co/eHWmGU0qEG
@ClinicalPck
“Determinants of #COVID__19 disease severity in patients with cancer | Nature Medicine” #Age older than 65 years and treatment with immune checkpoint inhibitors (ICIs) were predictors for hospitalization and severe disease https://t.co/IW8tWafGVu
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @Transplant_Doc: Determinants of #COVID__19 disease severity in patients with #cancer https://t.co/I1O7NKjtsj @NatureMedicine #coronavi…
RT @CDebyaniPhD: Intriguing research of our times: pts w/ cancer = 8.4% of ~9.3K deaths due to #COVID19 in #NewYork. @mini_kamboj @MichaelG…
Intriguing research of our times: pts w/ cancer = 8.4% of ~9.3K deaths due to #COVID19 in #NewYork. @mini_kamboj @MichaelGlickma1 @wolchokj et al show @sloan_kettering trtmt w/ immunotx was a predictor for COVID19 assoc hospitalization & severe disease
Determinants of #COVID__19 disease severity in patients with #cancer https://t.co/I1O7NKjtsj @NatureMedicine #coronavirus
RT @AMartinezRocaMD: Determinants of COVID-19 disease severity in patients with cancer. #COVID__19 #oncoalert https://t.co/eHWmGU0qEG
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @ZainabShd: Determinants of COVID-19 disease severity in patients with cancer | Nature Medicine https://t.co/09qLyROsns
“Age older than 65 years and treatment with immune checkpoint inhibitors were predictors for hospitalization and severe disease, whereas receipt of chemotherapy and major surgery were not.” #IDtwitter #covid19 https://t.co/tYtY17r6qt
Determinants of COVID-19 disease severity in patients with cancer | Nature Medicine https://t.co/09qLyROsns
RT @JohnNosta: Determinants of COVID-19 disease severity in patients with #cancer | Nature Medicine. #COVID19 @#coronavirus @jbuell01 ht…
Determinants of COVID-19 disease severity in patients with #cancer | Nature Medicine. #COVID19 @#coronavirus @jbuell01 https://t.co/YZspJJgjOG
RT @SaheliSadanand: Watching the #COVID19 and #Cancer Research #AACR20 Special Session right now? Check out this paper published today! 👇 @…
RT @nresearchnews: A paper in @NatureMedicine suggests that advanced cancer, receipt of chemotherapy and recent cancer surgery might not ex…
RT @DrMiguelPerales: #ASTCTChat @sloan_kettering paper just out today in @NatureMedicine Determinants of COVID-19 disease severity in patie…
RT @AMartinezRocaMD: Determinants of COVID-19 disease severity in patients with cancer. #COVID__19 #oncoalert https://t.co/eHWmGU0qEG
RT @AMartinezRocaMD: Determinants of COVID-19 disease severity in patients with cancer. #COVID__19 #oncoalert https://t.co/eHWmGU0qEG
RT @DrMiguelPerales: #ASTCTChat @sloan_kettering paper just out today in @NatureMedicine Determinants of COVID-19 disease severity in patie…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @sloan_kettering: 🚨 New MSK study published today in @NatureMedicine shows most cancer treatments don't worsen #COVID19 infection. https…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @tmhohl71: 1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer pati…
RT @DrMiguelPerales: #ASTCTChat @sloan_kettering paper just out today in @NatureMedicine Determinants of COVID-19 disease severity in patie…
Determinants of COVID-19 disease severity in patients with cancer https://t.co/B3jnoA57dB https://t.co/qVMEl8k0ar
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…
RT @NatureMedicine: Analysis of a large, single-center cohort of patients with cancer who were infected with #COVID19 uncovers factors asso…